A new non-invasive approach based on polyhexamethylene biguanide increases the regression rate of HPV infection

BMC Clinical Pathology

Volumn 12, Issue , 2012, Pages

  Gentile, Antonio ^a   Gerli, Sandro ^b   Di Renzo, Gian Carlo ^b  

^a ASP Messina   (Italy)

^b UNIVERSITY OF PERUGIA   (Italy)

Author keywords

HPV; Intraepithelial lesions; Polyhexamethylene biguanide; Regression rate

Indexed keywords

MONOGIN; POLY(HEXAMETHYLENEBIGUANIDE); UNCLASSIFIED DRUG;

ADULT; ARTICLE; CLINICAL EFFECTIVENESS; CLINICAL PROTOCOL; COLPOSCOPY; CONTROLLED STUDY; DRUG EFFICACY; DRUG SAFETY; FEMALE; HUMAN; LONG TERM CARE; MAJOR CLINICAL STUDY; MEDICAL HISTORY; PAPANICOLAOU TEST; PAPILLOMAVIRUS INFECTION; QUESTIONNAIRE; REMISSION; VIRAL CLEARANCE;

EID: 84866554637     PISSN: None     EISSN: 14726890     Source Type: Journal    
DOI: 10.1186/1472-6890-12-17     Document Type: Article

References (24)

1. Human papillomavirus infection and anxiety: analyses in women with low-grade cervical cytological abnormalities unaware of their infection status. Johnson CY, Sharp L, Cotton SC, Harris CA, Gray NM, Little J, PLoS One 2011 6 6 21046 10.1371/journal.pone.0021046 21698168
2. Epidemiology of, and behavioural risk factors for, sexually transmitted human papillomavirus infection in men and women in Britain. Johnson AM, Mercer CH, Beddows S, de Silva N, Desai S, Howell-Jones R, Carder C, Sonnenberg P, Fenton KA, Lowndes C, et al. Sex Transm Infect 2012 88 3 212 217 10.1136/sextrans-2011-050306 22261135
3. Triage of women with low-grade cervical lesions-HPV mRNA testing versus repeat cytology. Sorbye SW, Arbyn M, Fismen S, Gutteberg TJ, Mortensen ES, PLoS One 2011 6 8 24083 10.1371/journal.pone.0024083 21918682
4. Cox JT, Massad LS, Twiggs LB, Wilkinson EJ: 2001 Consensus Guidelines for the management of women with cervical cytological abnormalities. Wright TC Jr, JAMA 2002 287 16 2120 2129 10.1001/jama.287.16.2120 11966387
5. Update on the diagnosis and treatment of human papillomavirus infection. Zanotti KM, Belinson J, Cleve Clin J Med 2002 69 12 948 951-945, 956 passim 10.3949/ccjm.69.12.948 12546268
6. HPV infection and number of lifetime sexual partners are strong predictors for 'natural' regression of CIN 2 and 3. Chan JK, Monk BJ, Brewer C, Keefe KA, Osann K, McMeekin S, Rose GS, Youssef M, Wilczynski SP, Meyskens FL, et al. Br J Cancer 2003 89 6 1062 1066 10.1038/sj.bjc.6601196 12966426
7. Review on the efficacy, safety and clinical applications of polihexanide, a modern wound antiseptic. Hubner NO, Kramer A, Skin Pharmacol Physiol 2010 23 Suppl 17 27 20829658
8. In vitro and in vivo effects of polyhexamethylene biguanide against herpes simplex virus infection. Valluri S, Fleming TP, Laycock KA, Tarle IS, Goldberg MA, Garcia-Ferrer FJ, Essary LR, Pepose JS, Cornea 1997 16 5 556 559 9294689
9. Structure-activity relationships of polybiguanides with activity against human immunodeficiency virus type 1. Passic SR, Ferguson ML, Catalone BJ, Kish-Catalone T, Kholodovych V, Zhu W, Welsh W, Rando R, Howett MK, Wigdahl B, et al. Biomed Pharmacother 2010 64 10 723 732 10.1016/j.biopha.2010.10.001 21106331
10. The 2001 Bethesda System: terminology for reporting results of cervical cytology. Solomon D, Davey D, Kurman R, Moriarty A, O'Connor D, Prey M, Raab S, Sherman M, Wilbur D, Wright T Jr, et al. JAMA 2002 287 16 2114 2119 10.1001/jama.287.16.2114 11966386
11. Sellors JW, Sankaranarayanan R, Colposcopy and Treatment of Cervical Intraepithelial Neoplasia World Health Organization: A Beginners' Manual 2003
12. Chapter 1: HPV in the etiology of human cancer. Munoz N, Castellsague X, de Gonzalez AB, Gissmann L, Vaccine 2006 24 3 1 10 16122853
13. Natural history of cervicovaginal papillomavirus infection in young women. Ho GY, Bierman R, Beardsley L, Chang CJ, Burk RD, N Engl J Med 1998 338 7 423 428 10.1056/NEJM199802123380703 9459645
14. Polybiguanides, particularly polyethylene hexamethylene biguanide, have activity against human immunodeficiency virus type 1. Krebs FC, Miller SR, Ferguson ML, Labib M, Rando RF, Wigdahl B, Biomed Pharmacother 2005 59 8 438 445 10.1016/j.biopha.2005.07.007 16154720
15. Polyhexamethylene biguanide for treatment of external genital warts: a prospective, double-blind, randomized study. Marelli G, Papaleo E, Origoni M, Caputo L, Ferrari A, Eur Rev Med Pharmacol Sci 2005 9 6 369 372 16479742
16. Pseudomonas aeruginosa-induced infection and degradation of human wound fluid and skin proteins ex vivo are eradicated by a synthetic cationic polymer. Werthen M, Davoudi M, Sonesson A, Nitsche DP, Morgelin M, Blom K, Schmidtchen A, J Antimicrob Chemother 2004 54 4 772 779 10.1093/jac/dkh407 15355938
17. Bacterial decontamination of surgical wounds treated with Lavasept. Fabry W, Trampenau C, Bettag C, Handschin AE, Lettgen B, Huber FX, Hillmeier J, Kock HJ, Int J Hyg Environ Health 2006 209 6 567 573 10.1016/j.ijheh.2006.03.008 16872896
18. alpha(6) Integrin is the main receptor of human papillomavirus type 16 VLP. Yoon CS, Kim KD, Park SN, Cheong SW, Biochem Biophys Res Commun 2001 283 3 668 673 10.1006/bbrc.2001.4838 11341777
19. The L1 major capsid protein of human papillomavirus type 11 recombinant virus-like particles interacts with heparin and cell-surface glycosaminoglycans on human keratinocytes. Joyce JG, Tung JS, Przysiecki CT, Cook JC, Lehman ED, Sands JA, Jansen KU, Keller PM, J Biol Chem 1999 274 9 5810 5822 10.1074/jbc.274.9.5810 10026203
20. Signal transduction and signal modulation by cell adhesion receptors: the role of integrins, cadherins, immunoglobulin-cell adhesion molecules, and selectins. Aplin AE, Howe A, Alahari SK, Juliano RL, Pharmacol Rev 1998 50 2 197 263 9647866
21. Function and interactions of integrins. Van der Flier A, Sonnenberg A, Cell Tissue Res 2001 305 3 285 298 10.1007/s004410100417 11572082
22. Cationic antiseptics: diversity of action under a common epithet. Gilbert P, Moore LE, J Appl Microbiol 2005 99 4 703 715 10.1111/j.1365-2672.2005.02664. x 16162221
23. Metal chelators as antiviral agents. Kirschberg T, Parrish J, Curr Opin Drug Discov Devel 2007 10 4 460 472 17659488
24. The initial steps leading to papillomavirus infection occur on the basement membrane prior to cell surface binding. Kines RC, Thompson CD, Lowy DR, Schiller JT, Day PM, Proc Natl Acad Sci U S A 2009 106 48 20458 20463 10.1073/pnas.0908502106 19920181